Harvest One Reports Favorable Satipharm Clinical Trial Results

New Cannabis Ventures
By NCV NewswireJul 24, 2018, 9:22 am83 pts
Positive Final Results Returned from Phase 2 Clinical Trials using Satipharm Capsules VANCOUVER, July 24, 2018 /CNW/ – Harvest One Cannabis Inc. (TSXV: HVT) (“Harvest One” or the “Company”), through its wholly-owned subsidiary Satipharm AG (“Satipharm”), is pleased to advise that positive results…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Goldflower Cannabis Opening 10th Florida Medical Dispensary in Lakeland 47

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.